• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经泪小管激光辅助泪囊鼻腔造口术后硅胶管上微生物生长的研究及其与通畅性的相关性。

Study of microbial growth on silicone tubes after transcanalicular laser-assisted dacryocystorhinostomy and correlation with patency.

作者信息

Goel R, Nagpal S, Kamal S, Kumar S, Mishra B, Loomba P S

出版信息

Nepal J Ophthalmol. 2016 Jul;8(16):119-127. doi: 10.3126/nepjoph.v8i2.16992.

DOI:10.3126/nepjoph.v8i2.16992
PMID:28478465
Abstract

INTRODUCTION

Intubation in primary transcanalicular laser assisted dacryocystorhinostomy (TCLADCR) is performed to increase the success rates. However, the associated inflammation and infection can have adverse effects.

OBJECTIVE

To study the microbial infection and drug susceptibility of extubated silicone tubes and final anatomical patency in patients undergoing TCLADCR.

MATERIALS AND METHODS

A non-randomised prospective interventional study was conducted in a tertiary care eye centre. The study included twenty consecutive adult patients with primary nasolacrimal duct obstruction. They underwent TCLADCR with bicanalicular silicone intubation. The stents were removed at 2 months and subjected to culture sensitivity, followed by administration of appropriate antimicrobial agents. Main outcome measures studied were the microbial spectrum on the cultured tubes, their sensitivity profile and its correlation with final anatomical patency.

RESULTS

A positive culture was obtained in 100% cases, comprising of normal commensals and pathogenic organisms. Of the total 24 isolates, 16 (66.6%) Gram positive bacteria (75% Staphylococcus aureus) and 8 (33.3%) Gram negative bacteria (commonest E.coli) were found, with 4 tubes having more than one isolate. No fungal growth was seen. Ninety percent success rate was achieved at one year following appropriate antimicrobial therapy except in 2 patients with gram negative isolates who had failed to take the prescribed antibiotics following sensitivity reports. There was no correlation between multiple infections and success rate. However, by using the Fisher exact test, a positive correlation was obtained between appropriate antibiotic treatment and the final anatomical patency (p less than 0.05).

CONCLUSION

Silicone intubation predisposes to microbial growth, which if neglected, can lead to failure of TCLADCR.

摘要

引言

在原发性经泪小管激光辅助泪囊鼻腔造口术(TCLADCR)中进行插管是为了提高成功率。然而,相关的炎症和感染可能会产生不良影响。

目的

研究接受TCLADCR的患者拔管后的硅胶管微生物感染及药敏情况,以及最终的解剖通畅情况。

材料与方法

在一家三级眼科护理中心进行了一项非随机前瞻性干预研究。该研究纳入了20例连续的成年原发性鼻泪管阻塞患者。他们接受了双泪小管硅胶插管的TCLADCR。支架在2个月时取出并进行培养药敏试验,随后给予适当的抗菌药物。研究的主要观察指标是培养管上的微生物谱、它们的药敏情况及其与最终解剖通畅的相关性。

结果

100%的病例培养结果呈阳性,包括正常共生菌和病原菌。在总共24株分离菌中,发现16株(66.6%)革兰氏阳性菌(75%为金黄色葡萄球菌)和8株(33.3%)革兰氏阴性菌(最常见的是大肠杆菌),4根管子有不止一种分离菌。未发现真菌生长。除2例革兰氏阴性菌分离株患者在药敏报告后未按规定服用抗生素外,适当的抗菌治疗后一年的成功率达到90%。多重感染与成功率之间无相关性。然而,通过Fisher精确检验,适当的抗生素治疗与最终的解剖通畅之间存在正相关(p小于0.05)。

结论

硅胶插管易导致微生物生长,如果忽视,可能导致TCLADCR失败。

相似文献

1
Study of microbial growth on silicone tubes after transcanalicular laser-assisted dacryocystorhinostomy and correlation with patency.经泪小管激光辅助泪囊鼻腔造口术后硅胶管上微生物生长的研究及其与通畅性的相关性。
Nepal J Ophthalmol. 2016 Jul;8(16):119-127. doi: 10.3126/nepjoph.v8i2.16992.
2
Clinical significance of microbial growth on the surfaces of silicone tubes removed from dacryocystorhinostomy patients.经鼻内窥镜鼻腔泪囊吻合术后取出的硅胶管表面微生物生长的临床意义。
Am J Ophthalmol. 2012 Feb;153(2):253-257.e1. doi: 10.1016/j.ajo.2011.06.030. Epub 2011 Sep 13.
3
The microbiological spectrum and antibiotic sensitivity profile of extubated silicone stents following dacryocystorhinostomy.泪囊鼻腔造口术后拔管硅胶支架的微生物谱及抗生素敏感性分析
Orbit. 2013 Oct;32(5):298-303. doi: 10.3109/01676830.2013.815231.
4
Transcanalicular Laser-Assisted Dacryocystorhinostomy With Endonasal Augmentation in Primary Nasolacrimal Duct Obstruction: Our Experience.经泪小管激光辅助泪囊鼻腔造口术联合鼻内增强术治疗原发性鼻泪管阻塞:我们的经验
Ophthalmic Plast Reconstr Surg. 2017 Nov/Dec;33(6):408-412. doi: 10.1097/IOP.0000000000000802.
5
[Transcanalicular Laser Dacryocystorhinostomy: One-Year-Experience in the Treatment of Acquired Nasolacrimal Duct Obstructions].[经泪小管激光泪囊鼻腔造口术:治疗后天性鼻泪管阻塞的一年经验]
Klin Monbl Augenheilkd. 2016 Feb;233(2):182-6. doi: 10.1055/s-0041-106653. Epub 2015 Nov 26.
6
The Microbiological Profile of Bicanalicular Silicone Tubes Placed During External Dacryocystorhinostomy.外路泪囊鼻腔吻合术中植入双腔硅胶管的微生物学特征。
Turk J Ophthalmol. 2021 Aug 27;51(4):212-217. doi: 10.4274/tjo.galenos.2020.47639.
7
Bicanalicular Silicone Stents in Endonasal Dacryocystorhinostomy: Results of a Randomized Clinical Trial.经鼻内镜鼻腔泪囊吻合术中双泪小管内留置硅胶管:一项随机临床试验的结果。
Ophthalmology. 2016 Oct;123(10):2255-9. doi: 10.1016/j.ophtha.2016.06.026. Epub 2016 Jul 16.
8
Cultures of Proximal and Distal Segments of Silicone Tubes After Dacryocystorhinostomy.泪囊鼻腔吻合术后硅胶管近、远段的培养。
Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb;35(1):42-44. doi: 10.1097/IOP.0000000000001149.
9
A meta-analysis of primary dacryocystorhinostomy with and without silicone intubation.原发性泪囊鼻腔吻合术联合与不联合硅胶管置入的荟萃分析
Can J Ophthalmol. 2011 Dec;46(6):521-7. doi: 10.1016/j.jcjo.2011.09.008.
10
Randomized trial on silicone intubation in endoscopic mechanical dacryocystorhinostomy (SEND) for primary nasolacrimal duct obstruction.随机试验研究在原发性鼻泪管阻塞的内镜下机械泪囊鼻腔吻合术中应用硅胶插管(SEND)。
Ophthalmology. 2013 Oct;120(10):2139-45. doi: 10.1016/j.ophtha.2013.02.036. Epub 2013 May 11.

引用本文的文献

1
Should Silicone Lacrimal Stenting be a Better Choice for Primary Endoscopic Powered Dacryocystorhinostomy?硅胶泪道支架对于原发性内镜动力性泪囊鼻腔造口术来说是否是更好的选择?
Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):496-502. doi: 10.1007/s12070-022-03299-4. Epub 2022 Dec 11.
2
The Microbiological Profile of Bicanalicular Silicone Tubes Placed During External Dacryocystorhinostomy.外路泪囊鼻腔吻合术中植入双腔硅胶管的微生物学特征。
Turk J Ophthalmol. 2021 Aug 27;51(4):212-217. doi: 10.4274/tjo.galenos.2020.47639.